Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ DIP and RIP Message Board

$BPTH,,,Another stock I keep on my radar,,,finishe

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 23117
(Total Views: 180)
Posted On: 07/19/2017 9:13:48 AM
Avatar
Posted By: OldSaltDawg
$BPTH,,,Another stock I keep on my radar,,,finished the day yesterday @ $.39 and up $.03 in After Hours right now. This stock has been consolidating and trading at the $.40 level since June 1st. All of the indicators I look at are heading in the positive direction. As with the other stocks I have mentioned, this needs to see some volume as yesterday was below the average daily volume. I will see how this shakes out this morning.

Following explains where this company currently presently looks:

Bio-Path Holdings (BPTH) Is At $0.43

Bio-Path Holdings Inc (BPTH) formed wedge down with $0.41 target or 5.00% below today’s $0.43 share price. Bio-Path Holdings Inc (BPTH) has $38.22 million valuation. About shares traded. Bio-Path Holdings Inc (NASDAQ:BPTH) has declined 82.37% since July 19, 2016 and is downtrending. It has underperformed by 99.07% the S&P500.

Investors sentiment increased to 1.93 in 2016 Q4. Its up 0.01, from 1.92 in 2016Q3. It increased, as 5 investors sold Bio-Path Holdings Inc shares while 9 reduced holdings. 9 funds opened positions while 18 raised stakes. 19.14 million shares or 4.05% less from 19.95 million shares in 2016Q3 were reported. Geode Cap Management Limited Company owns 682,477 shares. Credit Suisse Ag invested 0% of its portfolio in Bio-Path Holdings Inc (NASDAQ:BPTH). Blackrock Advsr Ltd Limited Liability Company reported 49,387 shares. Voya Investment Mngmt Ltd holds 44,232 shares. Proshare Ltd Limited Liability Company reported 0% stake. Amalgamated Comml Bank reported 10,845 shares or 0% of all its holdings. Schwab Charles Investment Inc has 0% invested in Bio-Path Holdings Inc (NASDAQ:BPTH) for 131,200 shares. Rhumbline Advisers reported 0% of its portfolio in Bio-Path Holdings Inc (NASDAQ:BPTH). Tiaa Cref Management reported 0% in Bio-Path Holdings Inc (NASDAQ:BPTH). Jpmorgan Chase holds 0% or 120,669 shares. Kcg Hldg Incorporated reported 0% in Bio-Path Holdings Inc (NASDAQ:BPTH). Moreover, Morgan Stanley has 0% invested in Bio-Path Holdings Inc (NASDAQ:BPTH) for 257,550 shares. Barclays Public Ltd Liability Com accumulated 1,662 shares or 0% of the stock. Vanguard Grp Incorporated has 2.90 million shares for 0% of their portfolio. American Grp invested in 0% or 47,756 shares.

Analysts await Bio-Path Holdings Inc (NASDAQ:BPTH) to report earnings on August, 8. They expect $-0.02 earnings per share, 0.00% or $0.00 from last year’s $-0.02 per share. After $-0.01 actual earnings per share reported by Bio-Path Holdings Inc for the previous quarter, Wall Street now forecasts 100.00% negative EPS growth.



BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.


(0)
(0)




'Everything works out in the end,,,If it hasn't worked out,,it's not the end'


https://twitter.com/twitter/statuses/957208055766241280




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us